Driving the Sleep Apnea Oral Appliances Market

The global sleep apnea oral appliances market is expected to reach USD 0.9 billion by 2028 from USD 0.4 billion in 2023, at a CAGR of 15.2%.

The global market for Sleep Apnea Oral Appliances is experiencing rapid growth. In 2023, this market was valued at $0.4 billion. However, it is projected to reach $0.9 billion by 2028, expanding at an impressive compound annual growth rate (CAGR) of 15.2% during the forecast period of 2023 to 2028.

A key driver fueling this market’s expansion is the large pool of undiagnosed sleep apnea patients worldwide. Sleep apnea, a common sleep disorder affecting people across all age groups, is estimated to impact between 10% and 30% of adults in the United States alone, according to the American Sleep Apnea Association. With changing lifestyles contributing to rising obesity rates globally, the number of potential sleep apnea patients is likely to surge, presenting significant growth opportunities for oral appliance manufacturers.

Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105423877

While continuous positive airway pressure (CPAP) therapy remains an effective treatment for obstructive sleep apnea (OSA), poor patient compliance poses a challenge. Many patients struggle to adhere to the recommended usage of CPAP machines, often using them for fewer than four hours per night. This lack of adherence compromises the long-term health benefits of CPAP therapy, creating an opportunity for oral appliances as an alternative treatment option.

However, the sleep apnea oral appliances market also faces some hurdles. One major challenge is the high cost associated with customizing these devices to fit each patient’s unique oral anatomy. This customization process is time-intensive and limits the potential for mass production, making customized oral appliances less accessible than standard CPAP treatment for some patients.

The market is dominated by prominent players such as SomnoMed (Australia), ResMed (US), Whole You, Inc. (US), ProSomnus Sleep Technologies (US), and Vivos Therapeutic, Inc. (US). These companies are well-established, financially stable manufacturers with diversified product portfolios, state-of-the-art technologies, and strong global sales and marketing networks.

In terms of product segments, mandibular advancement devices are expected to dominate the market in 2022 due to their enhanced effectiveness and patient comfort. Additionally, physician-prescribed or customized oral appliances are anticipated to lead the market based on purchase type, as they offer a more patient-centric approach with individualized treatment plans.

Geographically, North America is poised to dominate the sleep apnea oral appliances market during the forecast period, driven by rising obesity rates, ongoing technological advancements in sleep apnea devices, and favorable regulatory and reimbursement scenarios.

With increasing awareness and diagnosis of sleep apnea, as well as the availability and accessibility of oral appliances, the sleep apnea oral appliances market is positioned for remarkable growth in the coming years.